HeartSciences Inc.

HSCS | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.68

-$0.52 (-10.00%)

At close: Sep 21, 2026, 4:00 PM ET

$4.41

-$0.27 (-5.81%)

Pre-market: Sep 22, 2026, 4:25 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-10.00%

(1D)

Rating

Updated: Sep 9, 2026

17.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $10.11M

1D Range

4.62 5.25

52W Range

1.63 5.25

Valuation (TTM)

PE -1.46

PB -4.97

EV/EBITDA 1.67

Valuation (NTM)

Forward PE N/A

Forward PEG 0.06

Price Target $3

Cash Flow

FCF Yield -13104.3%

SBC Adj. FCF Yield -20426.6%

SBC Impact -55.9%

Margins

Gross Margin -2908.8%

Operating Margin -209733.1%

FCF Margin -29306837.3%

Growth (CAGR)

Revenue 3Y | 5Y 32.3% | -27.4%

Dil EPS 3Y | 5Y 88.6% | 71.0%

FCF 3Y | 5Y -147.7% | -97.1%

Returns

ROA -274.5%

ROE -816.3%

ROIC -480.8%

Financial Health

Net Cash

$26.18M

Current Ratio 0.12

Interest Coverage -11.78

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ...

Sector Healthcare

Industry Medical - Devices

Employees 14

IPO Date Jun 15, 2022

Website heartsciences.com

Fiscal Year May - April

Full Company Profile

Latest News

No news articles available yet.

Earnings

Latest Earnings

Sep 14, 2026

EPS

-$0.86

Miss -19.44%

YoY: +45.57%

REV

$2.1K

Miss -97.90%

YoY: +10.53%

Next Earnings

Dec 21, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-35.90%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞